See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2024_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,530,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 75,000 |
| 3 | remainder_Assets | 650,000 |
| 4 | LiabilitiesCurrent | 20,777,000 |
| 5 | LiabilitiesNoncurrent | 100,000 |
| 6 | remainder_Liabilities | 5,696,000 |
| 7 | CostOfGoodsAndServicesSold | 8,395,658 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,278,031 |
| 9 | ResearchAndDevelopmentExpense | 1,703,228 |
| 10 | remainder_Expenses | 2,651,945 |
| 11 | remainder_Revenues | 63,122,039 |
| 12 | remainder_NetIncome | 13,269,281 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,255,000 |
| 1 | Liabilities | 26,573,000 |
| 2 | Expenses | 23,028,862 |
| 3 | Revenues | 63,122,039 |
| 4 | StockholdersEquity | -16,318,000 |
| 5 | NetIncome | 53,362,458 |
| 6 | ComprehensiveNetIncome | 53,362,458 |
| 7 | BaseVar | 68,124,091 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.966 |
| 9 | EconomicCapitalRatio | 2.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
